Our business is split into three core areas. Generic Drug Substances (GDS) is still the heartland for many of our customers. Custom Manufacturing Solutions (CMS) is now nearly as large and is the fastest growing part of our business. Peptides is an expression of our expertise in a certain aspect of chemistry.
Neuland is at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company’s technical and scientific teams provide reliable solutions and services to the global pharmaceutical industry.
Neuland follows a strong set of ethical values, termed ‘The Neuland Way’, that spurs integrity and motivation among the work force. The Neuland Way is made up of five defined values: Customer Centricity; Reliability; Accountability; Ownership; Openness & Transparency; and the core of Neuland’s business is built upon these values.
The Neuland sales team was actively talking with clients and would-be clients. The big news was that Neuland has added a third facility and are getting it ready to add to the family.
We will be exhibiting again in 2018 at CPhI Worldwide in October. Come and see us in hall 5, booth number 5D11. We look forward to seeing you all there.
Contact us today to arrange a meeting.
Neuland & Generic Drug Substances (GDS)
Posted on May 19, 2018 by Saharsh Davuluri
From the day Neuland was established in 1984, our core business and operational expertise has been the manufacturing of Generic Drug Substances. More specifically, delivering niche, highly-specialized and complex synthetic…
Neuland is committed to its stakeholders for their sustainable and long-term enrichment. Investor Relations is a top priority and we aim to meet all expectations with timely and reliable information.
Neuland facilitates accelerated career growth for self-driven and motivated professionals who are willing to learn, explore and flourish with the company. If you would like to make a career with us in R&D, manufacturing, engineering, sales and marketing, finance, or supply chain management then we’d like to hear from you.